1. Anti-obesogenic effects of calcium prevent changes in the GLP-1 profile in adult rats primed by early weaning
    Fernanda Torres Quitete et al, 2015, Mol. Nutr. Food Res. CrossRef
  2. Liraglutide causes large and rapid epicardial fat reduction
    Gianluca Iacobellis et al, 2017, Obesity CrossRef
  3. Is cleaved glucagon-like peptide 1 really inactive? Effects of GLP-1(9-36) on human adipose stem cells
    Giulia Cantini et al, 2017, Molecular and Cellular Endocrinology CrossRef
  4. Gastrointestinal factors regulating lipid droplet formation in the intestine
    N. Auclair et al, 2018, Experimental Cell Research CrossRef
  5. Exendin-4 modifies adipogenesis of human adipose-derived stromal cells isolated from omentum through multiple mechanisms
    Xiaoying He et al, 2018, Int J Obes CrossRef
  6. Perspectives in GLP-1 Research: New Targets, New Receptors
    Giulia Cantini et al, 2016, Trends in Endocrinology & Metabolism CrossRef
  7. Additive effects of evogliptin in combination with pioglitazone on fasting glucose control through direct and indirect hepatic effects in diabetic mice
    Tae-Hyoung Kim et al, 2018, European Journal of Pharmacology CrossRef
  8. Short-term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity
    N. Shao et al, 2018, Andrologia CrossRef
  9. Epicardial Adipose Tissue feeding and overfeeding the Heart
    Gianluca Iacobellis et al, 2018, Nutrition CrossRef
  10. Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 Cell Extracts Inhibit Adipogenesis in 3T3-L1 and HepG2 Cells
    Woon Hee Jeung et al, 2018, Journal of Medicinal Food CrossRef
  11. The mechanisms of glycemic variability accelerate diabetic central neuropathy and diabetic peripheral neuropathy in diabetic rats
    Junpeng Yang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  12. Bioassay-guided isolation of active anti-adipogenic compound from royal jelly and the study of possible mechanisms
    Prakash Raj Pandeya et al, 2019, BMC Complement Altern Med CrossRef
  13. Anti-obesity effects of chondroitin sulfate oligosaccharides from the skate Raja pulchra
    Wen Li et al, 2019, Carbohydrate Polymers CrossRef
  14. Role of adipose tissue GLP-1R expression in metabolic improvement after bariatric surgery in patients with type 2 diabetes
    Miriam Ejarque et al, 2019, Sci Rep CrossRef
  15. In New-Onset Diabetes Mellitus, Metformin Reduces Fat Accumulation in the Liver, But Not in the Pancreas or Pericardium
    Gábor Zsóri et al, 2019, Metabolic Syndrome and Related Disorders CrossRef
  16. Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects
    Hongkai Zhang et al, 2015, Nat Commun CrossRef
  17. Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model.
    Yi-Chieh Li et al, 0 CrossRef
  18. The glucagon-like peptide 1 receptor agonist enhances intrinsic peroxisome proliferator-activated receptor γ activity in endothelial cells
    Hirohisa Onuma et al, 2014, Biochemical and Biophysical Research Communications CrossRef
  19. Irisin has no effect on lipolysis in 3T3-L1 adipocytes or fatty acid metabolism in HepG2 hepatocytes
    Chuan Wang et al, 2015, Endocrine CrossRef
  20. Effect of liraglutide on proliferation and differentiation of human adipose stem cells
    Giulia Cantini et al, 2015, Molecular and Cellular Endocrinology CrossRef
  21. Lipoprotein lipase and angiopoietin-like 4 – Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease
    Prasanth Puthanveetil et al, 2015, Critical Reviews in Clinical Laboratory Sciences CrossRef
  22. Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes
    Hye Min Lee et al, 2015, J Menopausal Med CrossRef
  23. Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes
    Rajaa El Bekay et al, 2016, British Journal of Pharmacology CrossRef
  24. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes
    N. González et al, 2017, Cardiovasc Diabetol CrossRef
  25. GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction
    Emilie Pastel et al, 2017 CrossRef
  26. Exendin-4 Improves Diabetic Kidney Disease in C57BL/6 Mice Independent of Brown Adipose Tissue Activation
    Shu Fang et al, 2020, Journal of Diabetes Research CrossRef
  27. Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities
    Vishal Vyas et al, 2019 CrossRef
  28. Effects of Semaglutide Versus Dulaglutide on Epicardial Fat Thickness in Subjects with Type 2 Diabetes and Obesity
    Gianluca Iacobellis et al, 2020 CrossRef
  29. null
    Gianluca Iacobellis, 2020 CrossRef
  30. The Anti-Inflammatory Effects of Glucagon-Like Peptide Receptor Agonist Lixisenatide on the Retinal Nuclear and Nerve Fiber Layers in an Animal Model of Early Type 2 Diabetes
    Yeon Woong Chung et al, 2020, The American Journal of Pathology CrossRef
  31. Liraglutide suppresses proliferation and induces adipogenic differentiation of 3T3-L1 cells via the Hippo-YAP signaling pathway
    Yongmei Li et al, 2018, Mol Med Report CrossRef
  32. Gut–adipose tissue crosstalk: A bridge to novel therapeutic targets in metabolic syndrome?
    Daniela Rosendo‐Silva et al, 2020, Obesity Reviews CrossRef
  33. Liraglutide and Insulin Have Contrary Effects on Adipogenesis of Human Adipose-Derived Stem Cells via Wnt Pathway


    Hong Liu et al, 2020, DMSO CrossRef
  34. The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation
    Abu-Farha Mohamed et al, 2020, Progress in Lipid Research CrossRef
  35. Low Molecular Pectin Inhibited the Lipid Accumulation by Upregulation of METTL7B
    Xiaojin Yang et al, 2021, Appl Biochem Biotechnol CrossRef
  36. Engineered Bacteria of MG1363-pMG36e-GLP-1 Attenuated Obesity-Induced by High Fat Diet in Mice
    Lingfang Wang et al, 2021, Front. Cell. Infect. Microbiol. CrossRef
  37. α-Poly-l-lysine functions as an adipogenic inducer in 3T3-L1 preadipocytes
    Kyeong Won Lee et al, 2021, Amino Acids CrossRef
  38. Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes?
    Emir M. Muzurović et al, 2021, J Cardiovasc Pharmacol Ther CrossRef
  39. Epicardial adipose tissue in obesity-related cardiac dysfunction
    Sarah L Ayton et al, 2021, Heart CrossRef
  40. Aging Effects on Epicardial Adipose Tissue
    Gianluca Iacobellis, 2021, Front. Aging CrossRef
  41. Anti‐adipogenic Effects of αAL14 Mediated by Modulation of PI3K/Akt Pathways in 3T3-L1 Cells
    Mi Jeong Jo et al, 2021, Int J Pept Res Ther CrossRef
  42. In vitro chronic glycation induces AGEs accumulation reducing insulin-stimulated glucose uptake and increasing GLP1R in adipocytes
    Nino-Cristiano Chilelli et al, 2021, American Journal of Physiology-Endocrinology and Metabolism CrossRef
  43. Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat
    G. Iacobellis et al, 2021, J Endocrinol Invest CrossRef